» Authors » Gian Marco Podda

Gian Marco Podda

Explore the profile of Gian Marco Podda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 424
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sterpone P, Donadini M, Abatangelo I, Tofanelli L, Raza A, Piacentino F, et al.
J Thromb Haemost . 2025 Jan; PMID: 39800258
Background: COVID-19 is associated with intense systemic inflammation and abnormal coagulation profile, leading to an increased incidence of pulmonary embolism (PE). Objectives: This study investigates whether PE in COVID-19 patients...
2.
Tombolini E, Squizzato A, Podda G, Aghemo A, Ferri N, Segato S, et al.
Liver Int . 2024 Dec; 45(2):e16177. PMID: 39736105
The natural history of chronic hepatitis C virus (HCV) infection has changed after the introduction of direct-acting antiviral agents (DAAs). Screening programs have been ongoing to reach the World Health...
3.
Ceriani E, Milani O, Donadoni M, Benetti A, Berra S, Canetta C, et al.
Intern Emerg Med . 2024 Dec; PMID: 39656348
The ongoing demographic, epidemiological and social changes are dramatically raising the clinical and care complexity of patients admitted to internal medicine (IM) departments. Collecting evidence for a better characterization of...
4.
Petito E, Bury L, Antunes Heck L, Sadler B, De Candia E, Podda G, et al.
Br J Haematol . 2024 Oct; 206(1):290-295. PMID: 39462764
No risk factors have been identified for vaccine-induced immune thrombotic thrombocytopenia (VITT) so far. The aim of this study was to identify human leucocyte antigen (HLA) alleles potentially associated with...
5.
Rocchetti F, Tenore G, Macali F, Vicidomini T, Podda G, Fantozzi P, et al.
Cancers (Basel) . 2024 Sep; 16(17). PMID: 39272848
This study aims to evaluate the expression of salivary and plasmatic miRNAs as diagnostic biomarkers in patients with oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs). A...
6.
Scavone M, Clerici B, Femia E, Ghali C, Fioretti A, Bossi E, et al.
Platelets . 2024 Jun; 35(1):2358241. PMID: 38832819
Acquired disorders of platelet function are an underdiagnosed cause of bleeding tendency. A 14-year-old girl developed moderate mucocutaneous bleeding two weeks after a infection successfully treated with clarithromycin. The patient...
7.
Palareti G, Antonucci E, Bucherini E, Caronna A, Chistolini A, Di Giorgio A, et al.
J Clin Med . 2024 Apr; 13(5). PMID: 38592175
Background: Patients with acute venous thromboembolism (VTE) need anticoagulation (AC) therapy for at least 3/6 months (primary treatment); after that period, they should receive a decision on the duration of...
8.
Ghali C, Scavone M, Clerici B, Bossi E, Fioretti A, Pisetta C, et al.
Br J Haematol . 2024 Mar; 204(5):2125-2128. PMID: 38471791
No abstract available.
9.
Clerici B, Birocchi S, Podda G
Eur J Intern Med . 2023 Dec; 119:34-35. PMID: 38123420
No abstract available.
10.
Clerici B, Pontisso E, Aloise C, Peroni B, Perricone R, Pisetta C, et al.
Thromb Haemost . 2023 Dec; 124(5):423-431. PMID: 38109906
Introduction:  Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a highly prothrombotic reaction to COVID-19 (coronavirus disease 2019) adenoviral vector vaccines. Its distinct bleeding and thrombotic patterns compared with other platelet consumptive...